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ABSTRACT 
Objectives: (1) Define parental perceptions of the Human Papillomavirus Vaccine and awareness of vaccine administration at 
community pharmacies (2) Describe parental intentions to have children vaccinated against HPV (3) Describe reasoning process behind 
parental vaccination intentions (4) Assess impact of pharmacist-led education on these perceptions and intentions 
Methods: This was a prospective pretest, posttest study with a convenience sample conducted at parenting groups throughout 
northern West Virginia in 2018.  Participants, a total of 34 parents/guardians, attended an educational session regarding Human 
Papillomavirus (HPV) vaccination with immediate pre/post survey.  The survey asked participants about their HPV vaccination history, 
personal perceptions regarding the HPV vaccine, age and gender of their children, overall immunization status of the child, current 
intent regarding the HPV vaccine, parents’ preferred resources for vaccine information, awareness of HPV vaccine availability in 
community pharmacies, as well as parent developed environment (rural, suburban, urban, etc.), race, age, marital status, education, 
and income level. 
Results: Following intervention, intention to vaccinate according to the Advisory Committee on Immunization Practices (ACIP) 
recommendations increased from 35% (n=12) to 44% (n=15).  The percentage of participants against vaccinating decreased from 23% 
(n=8) to 12% (n=4).  Participants demonstrated increased awareness of HPV vaccine availability at community pharmacies, with 
awareness increasing from 32% (n=11) to 100% (n=34). 
Conclusions: Pharmacist delivered education may be useful in increasing parent/legal guardian awareness of immunization services as 
well as intention to vaccinate their child. 
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Introduction 
Vaccination against communicable diseases and the 
subsequent decrease in mortality and morbidity from these 
diseases has often been viewed as the magnum opus of public 
health.  Public health practitioners have not only been able to 
see decreases in negative health outcomes from communicable 
diseases, but also the eradication of disease itself (as 
exemplified by smallpox)1.  However, achieving goal vaccination 
rates for various diseases remains a struggle.  Vaccination of the 
public against the human papillomavirus (HPV) is one such 
disease that remains suboptimal.   
 
Despite data supporting the use of the vaccine to prevent 
various types of cancer and genital warts2, vaccination rates 
remain far below Healthy People 2020 goals.  Healthy People 
goals are proposed by a consortium of health experts including 
the Centers for Disease Control and Prevention (CDC), Food and 
Drug Administration (FDA), and National Institute of Health 
(NIH) among others.  The goals are established each decade as  
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a benchmark for achieving a healthier population in a variety of 
topics.  The goal for complete HPV vaccination coverage (3 shot 
series according to available CDC vaccine schedule at time of 
goal authorship) is 80%3.  In West Virginia, just over 60% of 
female adolescents and 45% of males aged 13-17 have started 
the HPV series according to the 2015 National Immunization 
Survey-Teen (NIS-Teen)4.  However, 74% of females and 69% of 
males completed the HPV three-dose series after initiation, 
showing that completion rates are promising for those who 
begin vaccination.  West Virginia is also a primarily rural state, 
plagued by a lack of education regarding HPV.  In a recent 
analysis of Health Information National Trends Survey (HINTS)  
data, only 55.8% and 58.6% of rural residents respectively were 
even aware of HPV and the existence of an HPV vaccine5.  
Meanwhile, West Virginia remains among the top states 
regarding HPV related oropharyngeal cancer, HPV related 
cervical cancer, and cervical cancer deaths according to the CDC 
(rates of 5.1, 9.9, and 2.4 per 100,000 respectively)6,7.  
Pharmacists can play a key role in providing patient interaction 
and education regarding the HPV vaccine.   
 
Previous studies by Islam, McLean, and Gilkey have shown that 
convenient vaccination in pharmacies and strong professional 
recommendations can greatly increase vaccine uptake8-10.  Yet, 
uptake remains low despite increases in access and the 
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availability of studies supporting vaccination by pharmacists.  A 
qualitative study by Westrick in Alabama has shown that 
misinformation and lack of trust in pharmacists’ clinical 
qualifications are major barriers to vaccine uptake in the 
community pharmacy setting11.  Education is needed to combat 
misinformation regarding vaccines and pharmacists’ clinical 
abilities.  Studies by Winer, Reiter, and Kester have shown that 
group educational efforts can increase HPV vaccination 
knowledge as well as intention to vaccinate12-14.  In addition, 
studies by Loudon, Glanz, and Brunson have indicated that 
vaccination research and decisions are often made before the 
child is born or in early childhood15-17.  Such information can be 
used to tailor immunization-based educational interventions 
for maximal impact by incorporating appropriate timing into 
intervention design. 
 
While each of these studies addressed components of HPV 
vaccine education and intervention, none attempted such 
interventions with parents at such an early stage.  Considering 
the aforementioned study outcomes, it was imperative to 
educate parents during very early childhood about the HPV 
vaccine.  Furthermore, the HPV vaccine could not be delivered 
in the community pharmacy setting in West Virginia until 2018.  
Thus, no research or education about such access 
improvements had been completed.  This study sought to 
demonstrate the impact of a pharmacist-led group educational 
intervention on HPV vaccine awareness and intent of 
parents/legal guardians of young children (those under the age 
of 11-12). 
 
Methods 
This was a prospective pretest, posttest study with a 
convenience sample conducted at parenting groups throughout 
northern West Virginia.  The research protocol was approved 
by the Institutional Review Board of West Virginia University.  
Parenting groups contacted were formed for a variety of 
reasons.  Common reasons cited for group formation were 
common interests (i.e. hiking), socializing the young children 
(play groups), or involvement in a community organization 
(church groups or groups involved with high school child 
development classes).  A preliminary list of parenting groups 
was compiled using an internet based search engine.  Groups 
were recruited in a multimodal approach; utilizing phone, 
email, and social media.  Parents were informed of the 
educational session date by group administrators/facilitators.  
All children in these respective groups were under the age of 9, 
the youngest age for which the HPV vaccine is approved.  
Educational sessions were conducted during normal school 
hours; thus, the majority of children present at each group were 
aged 0-6.  Of note, some children did have siblings within the 
target age range for HPV vaccination, however families were 
not stratified based upon this data.  This project utilized 
primarily quantitative methods, with the option for additional 
open responses on several items.  When examining the 
reasoning behind decisions to avoid vaccination, open response 
items are imperative.  It is vital to analyze not only the 
percentage of participants who choose not to vaccinate, but to 
determine why they are not vaccinating.  Such data could be 
used to shape future research in the field.   
 
This study targeted parents with young children, who would be 
eligible for the HPV vaccine in the future.  Parents were 
excluded for inability (cannot write/read English) or 
unwillingness to complete the measurement tool, i.e. written 
survey.  They were also excluded due to previous participation 
if the parent was present in multiple parent groups selected for 
intervention.  Goal enrollment for the program was 
approximately 20 participants.  This was based upon the time 
and space requirements for program conduction, as well as 
response rates to residency-based research projects in years 
prior.  This goal was later surpassed as 34 parents participated.  
All parents who completed the educational intervention 
completed the survey.  One parent left prior to the educational 
session beginning after being alerted by parent group 
administrators of an injury to her child during the playgroup 
(conducted by parent group administrators/facilitators 
simultaneously to provide child-care).  This parent did not 
return to complete either the survey or the educational session. 
 
Data collection was performed via written survey.  The survey 
was a 17-item tool, which covered various items assessing 
vaccination history, perceptions, and intent as well as 
demographic information.  The survey asked participants about 
their HPV vaccination history, personal perceptions regarding 
the HPV vaccine, age and gender of their children, overall 
immunization status of the child, current intent regarding the 
HPV vaccine, parents preferred resources for vaccine 
information, awareness of HPV vaccine availability in 
community pharmacies, as well as parent developed 
environment (rural, suburban, urban, etc.), race, age, marital 
status, education, and income level.  Items were multiple 
choice, select all that apply, and open response.  Questions 
were developed independently by the study team and informed 
by HINTS and previous qualitative interviews by Brunson et al.15  
The survey was assessed for both face and content validity.  
Content was reviewed by an expert panel of frontline 
immunizers active in clinical practice, i.e. involved in state 
immunization organizations/efforts or clinical management 
roles.  The survey was administered to participants prior to the 
educational session and immediately following the session.  The 
program lasted approximately 30 minutes and included a short 
educational presentation (Microsoft PowerPoint®) with 
additional time allotted for questions to the pharmacist.  The 
program addressed HPV and related cancer prevalence in West 
Virginia, cervical cancer mortality in West Virginia, available 
HPV vaccine products, vaccine dosing schedule, locations for 
vaccination, vaccine efficacy and safety, and sexual behaviors in 
the context of HPV vaccination.  The educational program was 
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pharmacist-taught and delivered to multiple parent groups in 
West Virginia.  The pharmacist responsible for educational 
sessions was a community-based pharmacy resident with a 
Master’s in Public Health focusing on health behaviors.  
Educational programming and survey distribution took place 
from January to May 2018 with 4 total sessions occurring.  Final 
data analysis was performed in May 2018.  Due to the use of 
categorical data, convenience sampling methods, small sample 
size, and lack of a control group, descriptive statistics alone 
were used.  Percentages for each response were calculated and 
pre/posttest statistics compared using Microsoft Excel®. 
 
Results 
Participation 
Out of nineteen parenting groups contacted for participation in 
the study, five (26%) declined to participate.  Each of these 
groups cited religious and political beliefs as reasons for 
declining.    Eleven groups (58%) did not respond to the 
invitation to participate for unknown reasons. Only three 
groups (16%) opted to participate, with one group hosting at 
three separate locations and the remaining two groups hosting 
at one site each.  Of the participating groups, one group did not 
achieve any participants, likely due to a scheduling issue.  The 
organization had also scheduled an off-site field trip for all the 
children during the educational session. 
 
Demographics 
Of the participating parents/legal guardians, 91% (n=31) were 
Caucasian.  This is in line with the locale’s primarily Caucasian 
population.  The remaining participants were of Native 
American or Asian/Pacific Islander descent (n=3).  The study 
population was also relatively homogenous in age.  Forty-one 
percent (n=14) of the population was between the ages of 25-
34 and an additional 32% (n=11) was between the ages of 35-
44.  This result was expected considering the usual age at 
childbirth and our target population (parents with children 
under the age of 11-12).  The study population was relatively 
diverse in their educational levels.  Fifteen percent (n=5) of the 
population had attained a graduate/professional degree, 38% 
of the population had attained a bachelor’s degree, 6% of the 
population had attained an associate degree, 23% of the 
population had some college experience, and the remaining 
18% had attained a high school diploma or GED (Table 1).  No 
participants had less than a high school education or 
equivalent.  Note, of the 34 participants, only 29% (n=10) had 
received at least 1 dose of the HPV vaccine themselves, with 
just 14% (n=5) of the study population having completed the 
full three dose series of the HPV vaccine. Three participants 
chose not to answer this survey item.  The remaining 
participants (n=21) had not received any doses of the HPV 
vaccine. 
 
 
 
Vaccination Intentions and Perceptions 
Prior to completion of the educational session, only 35% (n=12) 
of participants intended to vaccinate their children according to 
the Advisory Committee on Immunization Practices (ACIP) 
recommendations by initiating the HPV vaccine series at age 11-
12.  However, 9% (n=3) already had another child in the ACIP 
recommended age range or older and had begun vaccination.  
Another 12% (n=4) intended to vaccinate their child at a later 
age.  Twenty-three percent (n=8) of the population did not 
intend to vaccinate.  The remaining 21% (n=7) of the population 
was unsure of whether they would vaccinate their children or 
chose not to respond.  Open response item explanations for 
such choices were safety and efficacy concerns and lack of 
information. This was further confirmed during the Q&A 
portion of the educational session.  The pharmacist was asked 
about vaccine safety and side effects at all parenting group 
educational sessions. Following completion of the intervention, 
44% (n=15) of the population intended to vaccinate at the ACIP 
recommended age.  Another 17% (n=6) intended to vaccinate 
their child at an age later than 11-12.  Again, 9% (n=3) had 
already begun vaccination.  Only 12% (n=4) of the population 
decidedly would not vaccinate their child, while 18% (n=6) were 
unsure or chose not to respond. (Figure 1 and 2).  Overall 
participants now intending to vaccinate (either at the ACIP 
recommended age or at a later age) increased by 14% following 
the intervention.  
 
Vaccine Decision-Making Process 
Of the 34 participants, 82% (n=28) indicated that they began 
making any vaccination decisions for their child prior to the 
child’s birth.  Of the remaining participants, 9% (n=3) indicated 
that they began making decisions for the child before they were 
one-year-old.  Only 1 participant (3%) indicated that they made 
vaccine decisions for the child after they were 10 years of age.  
The remaining 2 participants declined to answer.  Participants 
were also asked about their influences when making vaccine 
decisions.  In a “select all that apply” format survey item, 91% 
(n=31) of parents indicated that they used information from 
their doctor regarding vaccines. Only 6% (n=2) of parents relied 
on their pharmacist for vaccine information. Yet, 21% and 24% 
of participants used information from their family/friends and 
the internet, respectively.  Additionally, 15% (n=5) of 
participants used information from social media to inform their 
vaccine decisions (Figure 3). 
 
Awareness 
In addition, awareness of availability of the HPV vaccine at 
community pharmacies was assessed.  Prior to the intervention, 
only 32% (n=11) of participants were aware that the HPV 
vaccination was available to be administered at their 
community pharmacy.  Following the intervention, 100% (n=34) 
participants were aware that they could obtain the HPV vaccine 
at a community pharmacy.  Of note, vaccination in West 
Original Research COMMUNITY ENGAGEMENT 
 
http://z.umn.edu/INNOVATIONS                         2018, Vol. 9, No. 3, Article 8                         INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v9i3.1396 
4 
 
Virginia at the community pharmacy level continues to require 
a prescription for those age 11-18. 
 
Discussion 
With the preceding results, it can reasonably be concluded that 
educational interventions during early childhood may be 
effective for changing parental vaccine intentions regarding the 
HPV vaccine.  The participating groups showed a clear change 
in intention, as evidenced by the increase in the number of 
parents/guardians intending to vaccinate at either the ACIP 
recommended age or a later age, and the decrease in the 
number of participants who were decidedly not vaccinating 
their child. 
 
This study also helps to illuminate portions of the parent 
vaccine decision-making process.  The majority of parents made 
vaccination decisions prior to birth or very early in the child’s 
life.  Early intervention by healthcare practitioners, such as 
pharmacists, is vital for contacting parents when decisions are 
made, rather than trying to reverse a vaccine hesitant decision.  
Our research also revealed that the majority of parents 
continue to use their physician as a primary information source.  
While this is promising, as physicians are an excellent source for 
factual vaccination information, parents also used a variety of 
sources not verified for medical accuracy.  Healthcare providers 
must be aware of parents turning elsewhere for vaccine 
information, and be prepared to answer questions and 
concerns.  Pharmacists can take a proactive approach by asking 
all patients about vaccine status and concerns at each patient 
encounter. 
 
Community outreach can also increase public awareness of 
public health services offered at specific locations.  Participants 
were largely unaware of the ability to receive the HPV vaccine 
at community pharmacies prior to the educational session, but 
showed universal awareness following the intervention.  While 
the state of West Virginia did not allow pharmacies to 
administer the HPV vaccine to those age 11-18 prior to 2018, 
the service is now becoming widespread.  This study shows the 
importance of educating the public when new public health 
services become available.  Ideal utilization relies on an 
awareness of the service. 
 
This study had several limitations which call for further research 
in the field.  Limitations exist both in regards to study design 
and final study population.  This study utilized a brief, single 
instance with a snapshot style data capture.  No analysis for 
statistical significance could be performed due to small sample 
size and lack of control group.  While initial results look 
promising, further studies must be completed to determine 
whether such an intervention would have impact on actual 
vaccination rates later in a child’s life.  The final study 
population was also predominately white and female, limiting 
generalizability.  Non-response bias is undoubtedly present, as 
parenting groups specifically cited religious and political beliefs 
as primary reasons for non-participation.  These groups 
represent likely vaccine hesitant parents and could significantly 
impact study results.  Self-selection bias may also be present, as 
the parenting groups were formed prior to study conception by 
parent choice.  Furthermore, additional research is needed on 
whether a single intervention is sufficient to affect behavior as 
well as achieve the maximum number of participants affected.  
Continued interaction between the parent/legal guardian and a 
public health professional or healthcare provider may provide 
additional impact not captured within the scope of this study. 
 
Limitations also exist due to the legislative environment 
surrounding the study.  Pharmacist-provided HPV vaccination 
was newly available at the time of intervention due to state law 
expansion.  Given that time is an essential factor for 
dissemination of information, the dramatic increase in 
awareness of HPV vaccine availability at community pharmacies 
may not have been observed had the study been conducted at 
a later time.  HPV vaccines have only been available for a short 
period of time in the community setting in West Virginia.  As 
local community pharmacies adjust to the new legislation and 
begin roll-out of HPV vaccine advertisement campaigns, the 
baseline awareness is likely to be higher than what was found 
in this study.  Follow-up research retrospectively assessing 
awareness in additional parenting groups would provide a 
comparison for current data.  This would determine whether 
such an effect was observed due to lack of maturation of 
services or was a true knowledge gap for participants. 
 
During the course of the intervention, several parents shared 
that their vaccine intentions were shaped by fear of vaccine 
side effects and other vaccine-related dangers.  This was also 
reflected in free-form survey item responses (i.e. Other – please 
specify).  While many organizations such as the American Public 
Health Association and American Pharmacists Association have 
worked tirelessly to increase vaccine education including the 
limited occurrence of vaccine side effects and the lack of an 
association between vaccines and autism, various negative 
vaccine beliefs continue to persist.  Vaccine information is still 
garnered through multiple sources.  The ever growing role of 
social media, the Internet and validity of information provided 
cannot be underscored when assessing health-decision making 
regarding immunizations. Social media and the Internet are 
plagued with personal posts, blogs and websites that are not 
based on scientific truths regarding immunizations.  Nearly a 
quarter of participants that we surveyed stated that they relied 
on either information from family/friends, the Internet, or 
social media to inform their vaccine decisions.  It is our 
responsibility as public health professionals to take note of such 
information availability and educate the public accordingly. 
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Practice Implications 
Vaccination remains of paramount importance in public health 
within the last decade.  In a climate where vaccination decision 
making seems to be affected by websites, social media posts, 
and even Hollywood idols, public health practitioners and 
pharmacists are called to be at the forefront.  The public 
requires both the availability of vaccination services and 
education on the benefits/risks of vaccination.  Establishment 
of community relationships with faith-based and parental 
community groups will be vital for reaching vaccine-hesitant 
groups.  Specifically, partnerships between public health 
officials and pharmacists and community group influencers 
such as parish nurses, parent group organizers, and childcare 
facilities must be established.  This study has shown that 
educational outreach is a positive starting point for altering 
vaccination intentions.  Such efforts must be continued and 
grown to reach Healthy People 20203 goals.  Congruently, 
practitioners must continue to advocate for vaccine policy 
change.  Policy can greatly affect vaccine availability and 
convenience.  Although policies such as the West Virginia 
legislation allowing vaccination of children 11-18 year-olds with 
a prescription is a positive move towards vaccination goals, it is 
not enough.  Practitioners must continue to advocate for the 
expansion of vaccine offerings with fewer restrictions, 
particularly the HPV vaccine, in all 50 states. 
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Table 1 
Age % (n) Race % (n) Education Level % (n) 
18-24 15% (n=5) Caucasian 91% (n=31) HS Diploma/GED 18% (n=6) 
25-34 41% (n=14) Asian/PI 6% (n=2) Some College 23% (n=8) 
35-44 32% (n=11) Native 
American 
3% (n=1) Associate Degree 6% (n=2) 
45-54 6% (n=2)   Bachelor’s Degree 38% (n=13) 
Over 55 15% (n=5)   Graduate/Professional Degree 15% (n=5) 
 
 
        Figure 1        Figure 2 
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